Klotho, aging, and the failing kidney

S Buchanan, E Combet, P Stenvinkel… - Frontiers in …, 2020 - frontiersin.org
Klotho has been recognized as a gene involved in the aging process in mammals for over
30 years, where it regulates phosphate homeostasis and the activity of members of the …

The role of klotho in chronic kidney disease

D Zou, W Wu, Y He, S Ma, J Gao - BMC nephrology, 2018 - Springer
Chronic kidney disease (CKD) is an inherently systemic disease that refers to a long-term
loss of kidney function. The progression of CKD has repercussions for other organs, leading …

[HTML][HTML] Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy

MC Hu, M Shi, N Gillings, B Flores, M Takahashi… - Kidney international, 2017 - Elsevier
α-Klotho is highly expressed in the kidney, and its extracellular domain is cleaved and
released into the circulation. Chronic kidney disease (CKD) is a state of α-Klotho deficiency …

Klotho, oxidative stress, and mitochondrial damage in kidney disease

J Donate-Correa, B Martín-Carro, JB Cannata-Andía… - Antioxidants, 2023 - mdpi.com
Reducing oxidative stress stands at the center of a prevention and control strategy for
mitigating cellular senescence and aging. Kidney disease is characterized by a premature …

Soluble klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate

J Xie, J Yoon, SW An, M Kuro-o… - Journal of the American …, 2015 - journals.lww.com
Cardiac hypertrophy occurs in up to 95% of patients with CKD and increases their risk for
cardiovascular death. In the kidney, full-length membranous Klotho forms the coreceptor for …

[HTML][HTML] Changing bone patterns with progression of chronic kidney disease

TB Drüeke, ZA Massy - Kidney international, 2016 - Elsevier
It is commonly held that osteitis fibrosa and mixed uremic osteodystrophy are the
predominant forms of renal osteodystrophy in patients with chronic kidney disease. Osteitis …

Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population

A Covic, M Vervloet, ZA Massy, PU Torres… - The lancet Diabetes & …, 2018 - thelancet.com
The patient with chronic kidney disease (CKD) represents an extreme model for
arteriosclerosis, vascular calcification, and bone disorders, all of which are also associated …

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial

JA Udell, DL Bhatt, E Braunwald, MA Cavender… - Diabetes …, 2015 - Am Diabetes Assoc
OBJECTIVE The glycemic management of patients with type 2 diabetes mellitus (T2DM) and
renal impairment is challenging, with few treatment options. We investigated the effect of …

αKlotho mitigates progression of AKI to CKD through activation of autophagy

M Shi, B Flores, N Gillings, A Bian, HJ Cho… - Journal of the …, 2016 - journals.lww.com
AKI confers increased risk of progression to CKD. αKlotho is a cytoprotective protein, the
expression of which is reduced in AKI, but the relationship of αKlotho expression level to AKI …

The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody

SL Barker, J Pastor, D Carranza… - Nephrology Dialysis …, 2015 - academic.oup.com
Background αKlotho is the prototypic member of the Klotho family and is most highly
expressed in the kidney. αKlotho has pleiotropic biologic effects, and in the kidney, its …